UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...

Co-hosted by UC Santa Barbara Arts & Lectures and the Cancer Foundation of Santa Barbara, the talk will discuss CRISPR-Cas9 ...

Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...

Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jack Allen ...

The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow organs for people in need—but experts are also concerned about its potential ...

JonesTrading analyst Soumit Roy has assigned their bullish stance on EDIT stock, giving a Buy rating today. Soumit Roy’s rating is based ...

JonesTrading analyst Debanjana Chatterjee has assigned their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...

BMO Capital analyst Kostas Biliouris maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today and set a price ...

Plunkitt of Tammany Hall,” a collection of political sermons attributed to a crooked machine boss, is a handy reference for ...

Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...

Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate ...